Skip to main content
. Author manuscript; available in PMC: 2022 Feb 17.
Published in final edited form as: Biol Psychiatry. 2021 Sep 9;91(3):313–327. doi: 10.1016/j.biopsych.2021.05.029

Table 1.

Numbers of Cases and Controls for 18 Cohorts in the International Suicide Genetics Consortium

Cohort (Ancestry) SA Cases Controls
Psychiatric Genomics Consortium MDD (EUR) 1528 16,626
Psychiatric Genomics Consortium BIP (EUR) 3214 17,642
Psychiatric Genomics Consortium SCZ (EUR) 1640 7112
Psychiatric Genomics Consortium ED (EUR) 170 5070
Army STARRS (EUR) 670 10,637
German Borderline Genomics Consortium (EUR) 481 1653
UK Biobank (EUR) 2433 334,766
iPSYCH (EUR) 7003 52,227
Janssen (EUR) 255 1684
Yale-Penn (EUR) 475 1817
GISS Ukraine (EUR) 660 660
Columbia University (EUR) 577 1233
Australian Genetics of Depression Study and QSkin Study (EUR) 2792 20,193
University of Utah (EUR) 4692 20,702
Japan (EAS) 746 14,049
CONVERGE (EAS) 1148 6515
Grady Trauma Project (Admixed AA) 669 4473
Yale-Penn (Admixed AA) 629 2902
Total 29,782 519,961

AA, African American; Army STARRS, Army Study to Assess Risk and Resilience in Servicemembers; BIP, bipolar disorder; EAS, East Asian; ED, eating disorder; EUR, European; GISS, Genetic Investigation of Suicide and Suicide Attempt; MDD, major depressive disorder; SA, suicide attempt; SCZ, schizophrenia.